Supply and delivery of anti-infective medicines (antibiotics, antifungals, antiprotozoals, antivirals) to the department of health – contract to 30 september 2028

Bidders must be registered on the Central Supplier Database (CSD) and provide the CSD registration (MAAA number) for each entity in the bidding enterprise. Multi-entity bidders must complete the PBD 9.2 form with director details and enterprise categorisation. No other eligibility criteria are stated in the provided document.

Cell A4: Provide details of all directors for each entity in the bidding enterprise

The tender is for the supply and delivery of anti-infective medicines (antibiotics, antifungal, antiprotozoal and antiviral agents) to the Department of Health for the period ending 30 September 2028. The bid response spreadsheet lists 12 items with estimated quantities for the full tender period.

Bidders must complete the bid response spreadsheet for each item, providing the registered legal name, CSD number, delivered prices in ZAR (two decimals) not exceeding the SEP, product registration numbers, licence to manufacture medicines (number and expiry), pack sizes, lead times, batch capacity, barcodes, NAPPI codes, distributor and manufacturer details, API sources, and cost breakdown percentages. If any manufacturer or third party is a 3rd party to the bidder, complete PBD1. Prices must be quoted per unit and per shipper pack.

Bidders must be registered on the Central Supplier Database (CSD) and provide a CSD number. Bidders must hold a valid licence to manufacture medicines, with licence number and expiry date. Product registration numbers are required for each item. Pricing must not exceed the SEP for each item. Bidders must confirm whether any manufacturer or third party is a 3rd party to the bidder; if yes, complete PBD1.

The tender covers the supply and delivery of anti-infective medicines, including antibiotics, antifungal, antiprotozoal and antiviral agents. Specific items include: Aciclovir solution 200mg/5ml; 125ml (estimated 6,080 units), Amoxicillin 250mg/5ml suspension; 100ml (estimated 3,983,920 units), Amphotericin B 50mg injection; 1 vial (estimated 67,500 units), Benzylpenicillin 1 million unit injection; 1 vial (estimated 273,250 units), Benzylpenicillin 5 million unit injection; 1 vial (estimated 102,390 units), Dexamethasone and Chloramphenicol 0.1% / 0.5% eye drops; 5ml (estimated 57,420 units), Flucytosine 500mg scored tablet; 100 tablets (estimated 24,897 packs), Fosfomycin 3g sachet; 1 sachet (estimated 484,090 units), Ketoconazole 200mg tablet; 30 tablets (estimated 3,990 packs), Natamycin 50mg/ml eye drops; 15ml (estimated 870 units), Tobramycin 3mg/ml eye drops; 5ml (estimated 17,804 units), Primaquine 15mg tablets; 14 tablets (estimated 750 packs). Bidders must conform to specifications; deviations must be detailed. Lead time must be ≤14 calendar days, initial lead time ≤75 calendar days. Bidders must provide batch size and monthly batch capacity for each item.

Delivered prices must be quoted in ZAR with two decimals, per unit and per shipper pack. Prices may not exceed the SEP (current listing - corresponding unit). Bidders must provide a cost breakdown: % of delivered price attributable to API, formulation, packaging, logistics, and gross margin, indicating local vs imported for API, formulation, and packaging. Currency must be specified (ZAR, USD, GBP, EURO, DKK, CHF, AUD, INR, Yuan, or Other).

Bidders must be registered on the Central Supplier Database (CSD) and provide a CSD number. Bidders must hold a valid licence to manufacture medicines, with licence number and expiry date. Product registration numbers are required for each item. If any manufacturer or third party is a 3rd party to the bidder, complete PBD1. Bidders must provide EAN 13 barcodes for unit and shelf packs, ITF14 barcode for shipper pack, and 2D barcode or similar. NAPPI codes are required.

Closing date: 5 October 2026 at 11:00 am. Briefing session: non-compulsory online briefing via MS Teams on 18 September 2026 at 10H00. Bidders may join using the MS Teams link provided in the tender notice.

All inquiries must be emailed to [email protected]. Office hours are 07h30 to 15h30.

Bids must be delivered to the Department of Health, DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143. The bid document is obtainable from the Department of Health website (www.health.gov.za) and the e-tender portal on the National Treasury website. Bidders must click on the 'TENDERS' tab and then the 'PHARMACEUTICAL TENDERS' tab to download the bid document. All enquiries must be submitted to [email protected] in time to allow responses before the tender closes. Bids must be submitted before the closing time of 11:00 am on 5 October 2026.

The bid will be evaluated in four phases: Phase I – compliance with mandatory administrative bid requirements; Phase II – compliance with product, technical and legal mandatory requirements; Phase III – evaluation of B-BBEE compliance as per Section 9 of the Special Requirements and Conditions of Contract (SRCC); Phase IV – recommendation and award.

The tender is for the supply and delivery of anti-infective medicines, specifically antibiotics, antifungal, antiprotozoal and antiviral agents, to the Department of Health. The contract period ends on 30 September 2028.

Bidders must comply with mandatory administrative bid requirements (Phase I), product, technical and legal mandatory requirements (Phase II), and B-BBEE compliance as per Section 9 of the Special Requirements and Conditions of Contract (SRCC).

The bid will be evaluated in four phases: Phase I – compliance with mandatory administrative bid requirements; Phase II – compliance with product, technical and legal mandatory requirements; Phase III – B-BBEE compliance as per Section 9 of the SRCC; Phase IV – recommendation and award.

No eligibility criteria specified

Cell G2: Ownership or Director in related enterprise/s whether or not such enterprise/s are bidding in this tender? (Y/N)

Bidders must complete and submit PBD 9.1 (Directors' Categorisation) for the single bidding enterprise, disclosing for each director: full names, surname, nationality, identity or passport number, whether appointed as a director, executive or non-executive status, and any ownership or directorship in related enterprises (whether or not those enterprises are bidding). The form requires marking the relevant enterprise type: close corporation, company, incorporated joint venture, or listed company.

The tender is for the supply and delivery of anti-infective medicines (antibiotics, antifungal, antiprotozoal and antiviral agents) to the Department of Health for a period ending 30 September 2028. Bidders must hold valid licences to manufacture or import the offered products and provide valid Medicine Registration Certificates for each product.

Returnable documents — all must be completed, signed, and submitted in the exact order listed in the bid index:

• Covering Letter (CL) and Bid/File Index (BFI).
• PBD3: Bid Signature Authorisation — original or certified copy.
• SBD1: Invitation to Bid.
• PBD4.1: Contact Details of Bidder.
• CSD Registration Report.
• SARS Tax Clearance Pin.
• CIPC registration certificate.
• CIPC notice of change in Directors (if applicable).
• Proof of company ceding, mergers, acquisitions, and name changes (if applicable).
• PBD9.1: Entity Directors (single bidding entity) or PBD9.2: Multi-entity Bid.
• Identification documents of directors (certified copies).
• SBD4: Bidder's Disclosure.
• SBD6.1: Preference Points Claim.
• Valid B-BBEE Certificate (SANAS accredited) or sworn affidavit for EME/QSE.
• Multi-entity bids: certified copy of the agreement between entities.
• PBD11: Declaration of Financial Solvency and Business Rescue Status.
• PBD5: GMP Declaration of Compliance.
• SBD5: National Industrial Participation Programme.
• Valid licence to manufacture or import (in the bidder's name) with annexures — certified copies.
• Licence for local manufacturing sites (if applicable).
• Licence for complementary medicines (if applicable) with DA02 product list.
• Licence for medical devices or IVDs (if applicable).
• Valid Medicine Registration Certificates (MRC) for each product, marked with item number and filed numerically.
• MRC annexures and variation summaries (if applicable).
• PBD1: Third Party Authorisation Declaration and related forms (if sourcing from third party).
• Original Package Insert (PI) with QR code for each product.
• Proof of sample submission.
• Bidder's item list (BL).
• PBD8: SRCC and GCC Declaration of Compliance.
• Copy of SRCC and GCC — initial every page.
• Signed Excel Bid Response (Pricing Schedule) — if not signed, the bid will not be considered.
• USB flash drive with digital copy of the completed bid — each document saved as a separate file with admin code in the file name.

Submission requirements:

• All documents must be sorted, filed, and submitted in the exact order listed.
• If a document is not applicable, the bidder must explicitly indicate "N/A" and provide justification. Blacking out the N/A field is not acceptable.

Bidders must be registered on CSD, have a valid SARS Tax Clearance Pin, be registered with CIPC, and hold valid licences to manufacture or import the offered products. Bidders must provide valid Medicine Registration Certificates (MRC) for each product. B-BBEE status is required where applicable (certificate or sworn affidavit for EME/QSE). Multi-entity bids require a certified copy of the relevant agreement. Bidders must declare financial solvency and business rescue status (PBD11) and comply with GMP (PBD5). The signed pricing schedule is mandatory; failure to sign disqualifies the bid.

The tender covers the supply and delivery of anti-infective medicines, including antibiotics, antifungal, antiprotozoal, and antiviral agents, to the Department of Health. The contract period ends 30 September 2028. Bidders must hold valid licences to manufacture or import the offered products, and each product must have a valid Medicine Registration Certificate (MRC) issued by SAHPRA. The bidder's item list (BL) must list all products offered. Original package inserts with QR codes must be submitted for each product.

The signed Excel Bid Response (Pricing Schedule) is mandatory; failure to sign it disqualifies the bid. No other financial requirements are stated.

Mandatory compliance documents include:

• CSD registration report.
• SARS Tax Clearance Pin.
• CIPC registration certificate.
• Valid B-BBEE certificate (SANAS accredited) or sworn affidavit for EME/QSE.
• Valid licence to manufacture or import (in the bidder's name) with annexures.
• Valid Medicine Registration Certificates (MRC) for each product.
• PBD11: Declaration of Financial Solvency and Business Rescue Status.
• PBD5: GMP Declaration of Compliance.
• SBD5: National Industrial Participation Programme.
• PBD8: SRCC and GCC Declaration of Compliance.
• SBD4: Bidder's Disclosure.
• SBD6.1: Preference Points Claim.

Annexure B sets out the minimum data requirements for invoices under this contract. It defines the fields that must appear on every invoice for products delivered, covering invoice header, supplier information, contact details, delivery information, invoice details, order details, line items, summary totals, pay office information, and proof of delivery.

{"closingDate":"30 SEPTEMBER 2028"}

{"name":null,"email":null,"phone":null,"department":"OF HEALTH","address":"butor name Name of authorised distributor"}

7.3 Brand Name As per Contract Circular and Purchase Order

7.4 Name of Contract, relevant addenda (for prices) and

item number as per Contract Circular:

E.g. HP13-2013ARV_04_001

Contract#_Addendum#_It

em# The addenda number should have two placeholders

The item number should have three place holders

Item number should correspond

with Generic Product Description

7.5 Quantity Ordered Original requested quantity as per Purchase Order

7.6 Quantity Supplied The quantity of product delivered on this invoice

7.7 Batch number If there are multiple batch number per product then

each batch must appear on a separate line with the

appropriate quantity

7.8 Expiry If there are multiple expiry dates per product then

each expiry must appear on a separate line with the

appropriate quantity

Page | 3

HP02-2025AI/02: supply and delivery of anti-infective medicines (antibiotics,

Antifungal, antiprotozoal and antiviral agents) to the department of health

For the period ending 30 september 2028

7.9 Unit price (VAT INC) Unit Price as per Contract Circular or addendum which

includes VAT and delivery, must be to 4 (four) decimal

points.

7.10 Total Unit Price multiplied by the delivered quantity

Summary invoice line information

8 Field Definition

8.1 Total Ex VAT To 2 (two) decimal points

8.2 VAT amount To 2 (two) decimal points

8.3 Total Sum of Ex and VAT, to 2 (two) decimal points

'

‘Invoice To' information

9 Field Definition

9.1 Pay office Name Name of the entity holding the budget as per Purchase

Order Invoice To address

9.2 Pay office Address Address of the Invoice To entity as per Purchase

Order.

9.3 VAT # The VAT registration number of the entity buying the

goods as per Purchase Order

9.4 Pay Office Phone Telephone number of the Invoice To entity as per

Purchase Order

‘Goods Received By' information (Proof Of Delivery information)

10 Field Definition

10.1 Date Date goods were received

10.2 Name Print Name of person receiving and

singing for goods

10.3 PERSAL # PERSAL number of person receiving and signing for

goods.

10.4 Signature Signature of person receiving and signing for goods.

10.5 Number Cartons Received Indicate the number of cartons received for the invoice.

Page | 4

HP02-2025AI/02: supply and delivery of anti-infective medicines (antibiotics,

Antifungal, antiprotozoal and antiviral agents) to the department of health

For the period ending 30 september 2028

10.6 Facility stamp Sufficient space to allow the facility to stamp the

invoice without obscuring any detail on the invoice.

10.7 GRV number Space for Goods Received Voucher number to be

recorded on the invoice

10.8 Claim Reference Number Number of claim reference associated with delivery if

relevant

Page | 5

Invoices must show unit price including VAT and delivery, to four decimal places, as per the contract circular or addendum. Total line value is unit price multiplied by delivered quantity. Summary totals (ex VAT, VAT, and total) must be to two decimal places. Each invoice must reference a single purchase order number, and line items must include the contract and item number in the format Contract#_Addendum#_Item# (e.g. HP13-2013ARV_04_001).

Invoices must comply with the minimum data requirements in Annexure B. Each invoice must carry one of three headers: TAX INVOICE (original), COPY TAX INVOICE (supplier copy), or COPY TAX INVOICE (customer copy). Supplier information on the invoice must match the contract: supplier name, NDoH supplier code, CSD registration number, company registration number, VAT number, and distributor name if applicable. Contact details for public sector queries and debtors must appear. 'Deliver To' fields must match the purchase order: account number, facility name, demander code, Master Health Facility Number (MHFL), delivery address, delegated receiver's name and rank, and facility phone. Invoice details must include a unique invoice number with a 1D barcode, invoice date, and page numbers. Order details must reference a single purchase order number per invoice, with a 1D barcode, order captured date, and any special instructions. Line items must show EAN 13 barcode, generic product description, brand name, contract and item number (format Contract#_Addendum#_Item#), quantity ordered, quantity supplied, batch number and expiry (each batch/expiry on a separate line), unit price including VAT and delivery to four decimal places, and total line value. Summary totals must show total ex VAT, VAT amount, and total including VAT, each to two decimal places. 'Invoice To' information must show the pay office name, address, VAT number, and phone. Proof of delivery must record date received, receiver's printed name, PERSAL number, signature, number of cartons received, facility stamp, GRV number, and claim reference if relevant.

CSD registration number must appear on invoices, matching the supplier name on contract.

Supply and delivery of anti-infective medicines (antibiotics, antifungal, antiprotozoal and antiviral agents) to the Department of Health for the period ending 30 September 2028. Bid validity period: 180 days.

Closing date: 5 October 2026 at 11:00. Non-compulsory online briefing session via MS Teams on 18 September 2026 at 10:00.

Bidding process enquiries: [email protected]. Directorate: Access to Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria 0187. Tel: (012) 395 8130, Fax: (012) 395 8823/4.

Bids must be delivered to the Tender Box at the Directorate: Affordable Medicines, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, before the closing date and time. Late bids will not be accepted. All bids must be submitted on the official forms provided, not re-typed. The bid must remain valid for 180 days. Returnable documents include: SBD 1 (Invitation to Bid), SBD 4 (Bidder's Disclosure), SBD 5 (NIP declaration), SBD 6.1 (Preference Points Claim), SBD 7 (Contract Form, for successful bidder), SBD 8 (Declaration of Compliance with SRCC and GCC), SBD 9 (Certificate of Independent Bid Determination), PBD 1 (Authorisation Declaration, including third-party sourcing details), PBD 3/3.1 (Bid Signature Authorisation), PBD 5 (GMP Declaration), PBD 8 (Declaration of Compliance), PBD 9.1/9.2 (Directors' Categorisation), PBD 11 (Financial Solvency and Business Rescue Status), and proof of authority (e.g., company resolution). Bidders sourcing products from a third party must submit the completed PBD 1.1 and the third party's unconditional written undertaking (PBD 1.2).

Bid documents to be completed and submitted include: Bid Document Checklist (Paragraph 3), Bid Documents (Paragraph 4.1), Consortiums/Joint Ventures/Partnerships (Paragraph 4.3), Submission of bids (Paragraph 9), Completion of documents and bid submission (Paragraph 10).

The 90/10 preference point system applies: 90 points for price, 10 points for specific goals (B-BBEE status level of contributor). B-BBEE points: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, Non-compliant = 0. Specific goal: promotion of companies with higher B-BBEE contribution levels (Status Levels 1-4). Supporting evidence: valid SANAS accredited B-BBEE certificate or sworn affidavit for EME/QSE. Failure to submit valid evidence results in zero preference points, not disqualification. Bidders must be tax compliant, not in the service of the state, not listed on the Register for Tender Defaulters or List of Restricted Suppliers, and must disclose any relationship with state employees or interests in other enterprises.

Supply and delivery of anti-infective medicines (antibiotics, antifungal, antiprotozoal and antiviral agents) to the Department of Health for the period ending 30 September 2028. Bidders must comply with the Medicines and Related Substances Act for products offered, and must declare GMP compliance. Bidders must inform the Department at first knowledge of any circumstances that may result in interrupted supply.

Bidders must declare compliance with Good Manufacturing Practice (GMP) in terms of the Medicines and Related Substances Act, and undertake to inform the Department of Health of any circumstances that may result in interrupted supply.

Bidders must declare financial solvency and not be under business rescue, liquidation, sequestration, administration, or judicial management (PBD 11). They must notify the Department within 5 working days of any material financial event. False declarations may lead to disqualification, contract termination, reporting to National Treasury, or legal action. The National Industrial Participation (NIP) Programme applies to contracts with imported content equal to or exceeding US$10 million; successful bidders with contracts over R10 million must report to the DTI within 5 working days of award, and NIP obligations may be 30% of imported content.

Tax compliance: submit a SARS Tax Compliance Status (TCS) PIN or CSD number; each party in a consortium/JV/sub-contractor arrangement must submit a separate TCS certificate/PIN/CSD number. Bidders must not be persons in the service of the state, nor companies with directors who are persons in the service of the state. Bidders must not be listed in the Register for Tender Defaulters or the List of Restricted Suppliers. B-BBEE: valid SANAS accredited certificate or sworn affidavit (EME/QSE) required to claim preference points. GMP: declaration of compliance with Good Manufacturing Practice (PBD 5). Financial solvency declaration (PBD 11).

The applicable preference point system is the 90/10 system: 90 points for price, 10 points for specific goals (B-BBEE status level of contributor). Points for B-BBEE levels: Level 1: 10, Level 2: 9, Level 3: 8, Level 4: 6, Level 5: 5, Level 6: 4, Level 7: 3, Level 8: 2, Non-compliant: 0. Specific goal: promotion of companies with higher B-BBEE contribution levels (Status Levels 1-4). Supporting evidence: valid SANAS accredited B-BBEE certificate or sworn affidavit for EME/QSE.

This bid is subject to the Preferential Procurement Policy Framework Act, 2000, the Preferential Procurement Regulations 2022, the General Conditions of Contract (GCC), and any other Special Requirements and Conditions of Contract. The National Industrial Participation (NIP) Programme applies to contracts with imported content equal to or exceeding US$10 million. Successful bidders with contracts over R10 million must report to the DTI within 5 working days of award. NIP obligations may be 30% of imported content.

Bids must be delivered by the stipulated time to the correct address; late bids will not be accepted. All bids must be submitted on official forms. Bidders must ensure tax compliance and submit a SARS PIN or CSD number. No bids from persons in the service of the state or companies with directors in state service. Failure to comply may render the bid invalid.

{"name":null,"email":null,"phone":null,"department":null,"address":"or member."}

Preference points for specific goals are claimed under the Preferential Procurement Regulations, 2022. Bidders must submit a valid B-BBEE affidavit or certificate to receive these points; an incorrectly completed QSE/EME affidavit is invalid and no preference points are allocated.

B-BBEE compliance: QSEs (annual revenue between R10 million and R50 million) and EMEs (annual revenue less than R10 million) must submit a sworn affidavit; bidders with annual turnover exceeding R50 million must submit a valid SANAS-accredited B-BBEE certificate. The affidavit must be completed correctly and commissioned by a Commissioner of Oaths who is not an employee or ex officio of the enterprise. Key affidavit details: deponent name and ID, designation (director, owner or member), enterprise name and CIPC registration details, ownership percentages (black, black female, designated group), total revenue and basis (audited or management accounts), financial year end, B-BBEE status level, empowering supplier status, and matching signature dates.

Preference points for specific goals are claimed under the Preferential Procurement Regulations, 2022. An incorrectly completed QSE/EME affidavit is invalid and no preference points are allocated.